Maria Jung

CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients

Johannes Stein, Glen Kristiansen, G. Kristiansen, 2016, Epigenetics.